Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$32.87 - $43.55 $846,764 - $1.12 Million
25,761 New
25,761 $861,000
Q4 2022

Feb 13, 2023

BUY
$49.7 - $57.71 $1.52 Million - $1.77 Million
30,607 New
30,607 $1.56 Million
Q2 2022

Aug 04, 2022

SELL
$63.83 - $80.0 $7.37 Million - $9.23 Million
-115,400 Reduced 87.18%
16,964 $1.09 Million
Q1 2022

May 11, 2022

BUY
$76.85 - $89.45 $10.2 Million - $11.8 Million
132,364 New
132,364 $10.3 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $5.95 Million - $6.96 Million
-79,804 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $5.62 Million - $6.36 Million
76,116 Added 2063.88%
79,804 $6.42 Million
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $296,884 - $324,580
3,688 New
3,688 $297,000
Q4 2020

Feb 09, 2021

SELL
$75.39 - $82.36 $1.17 Million - $1.28 Million
-15,500 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $1.21 Million - $1.41 Million
15,500 New
15,500 $1.25 Million
Q2 2020

Aug 06, 2020

SELL
$78.66 - $94.14 $1.04 Million - $1.24 Million
-13,200 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$71.57 - $93.3 $944,723 - $1.23 Million
13,200 New
13,200 $1.07 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $13.3 Million - $16.8 Million
-206,054 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $12.7 Million - $16 Million
206,054 New
206,054 $13.6 Million
Q3 2018

Oct 18, 2018

SELL
$70.71 - $77.75 $11.2 Million - $12.3 Million
-157,823 Closed
0 $0
Q2 2018

Aug 07, 2018

SELL
$63.43 - $75.41 $1.92 Million - $2.28 Million
-30,200 Reduced 16.06%
157,823 $11.7 Million
Q1 2018

May 14, 2018

BUY
$62.56 - $72.26 $10.5 Million - $12.2 Million
168,300 Added 853.32%
188,023 $12.2 Million
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $1.21 Million - $1.3 Million
19,723
19,723 $1.28 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.